Gaudium IVF and Women Health Ltd
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]
- Market Cap ₹ 843 Cr.
- Current Price ₹ 116
- High / Low ₹ 164 / 69.2
- Stock P/E 36.4
- Book Value ₹ 20.9
- Dividend Yield 0.00 %
- ROCE 29.3 %
- ROE 24.7 %
- Face Value ₹ 5.00
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 187 days.
- Working capital days have increased from 39.9 days to 90.9 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| 37 | 44 | 48 | 71 | 104 | 106 | |
| 23 | 24 | 28 | 42 | 67 | 71 | |
| Operating Profit | 14 | 20 | 19 | 29 | 38 | 35 |
| OPM % | 37% | 46% | 41% | 41% | 36% | 33% |
| -0 | 0 | 0 | 0 | 0 | 2 | |
| Interest | 1 | 0 | 1 | 2 | 3 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 3 | 2 |
| Profit before tax | 12 | 18 | 17 | 25 | 32 | 31 |
| Tax % | 26% | 26% | 38% | 25% | 24% | |
| 9 | 14 | 10 | 19 | 24 | 23 | |
| EPS in Rs | 89.17 | 136.54 | 104.22 | 3.12 | 3.36 | 3.51 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 33% |
| TTM: | 48% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 22% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 34% |
| Last Year: | 25% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.99 | 0.99 | 0.99 | 31 | 36 |
| Reserves | 8 | 22 | 26 | 16 | 116 |
| 6 | 12 | 17 | 21 | 25 | |
| 3 | 2 | 7 | 22 | 16 | |
| Total Liabilities | 18 | 37 | 51 | 89 | 193 |
| 4 | 18 | 19 | 18 | 30 | |
| CWIP | 0 | 0 | 0 | 7 | -0 |
| Investments | -0 | -0 | -0 | 5 | 5 |
| 14 | 18 | 32 | 58 | 158 | |
| Total Assets | 18 | 37 | 51 | 89 | 193 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| -1 | 24 | 3 | 9 | 7 | |
| -1 | -16 | -5 | -15 | -88 | |
| 3 | 5 | -1 | 2 | 82 | |
| Net Cash Flow | 0 | 13 | -3 | -5 | 2 |
| Free Cash Flow | -2 | 9 | 1 | -0 | 5 |
| CFO/OP | 13% | 141% | 27% | 46% | 51% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 65 | 8 | 104 | 170 | 187 |
| Inventory Days | 29 | 111 | 168 | 175 | 38 |
| Days Payable | 114 | 77 | 62 | 338 | 133 |
| Cash Conversion Cycle | -20 | 41 | 210 | 7 | 92 |
| Working Capital Days | 61 | -52 | -15 | 44 | 91 |
| ROCE % | 76% | 45% | 49% | 29% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Average Revenue Per Patient (ARPP) INR Lakhs |
|
|||
| IVF Success Rate (First Attempt) % |
||||
| IVF Treatment Revenue Share % |
||||
| Number of Embryologists count |
||||
| Number of OPU (Ovum Pick-Ups) count |
||||
| International Patients Share % |
||||
| Number of Hubs count |
||||
| Number of Spokes count |
||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Intimation of Post Dispatch Newspaper Advertisement for the Notice of 11th Annual General Meeting and E-Voting Information
-
Weblink Letter To Shareholders - Pursuant To Regulation 36(1)(B) Of SEBI (LODR) Regulations, 2015
- 11th AGM on September 28, 2026; FY2025-26 annual report and e-voting details shared.
- Reg. 34 (1) Annual Report.
-
Notice Of 11Th Annual General Meeting Of The Company
- 11th AGM on September 28, 2026; approve FY26 financials, director remuneration, secretarial auditor appointment.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Gaudium IVF and Women Health Limited informed about copy of newspaper publication regarding Pre-AGM Notice of 11th Annual General Meeting to be held on Monday, …
Concalls
-
Aug 2026Transcript PPT REC
-
Aug 2026TranscriptAI SummaryPPT
-
May 2026Transcript PPT REC
Business Profile[1][2]
The company operates in the Assisted Reproductive Technology (ART) and IVF segment in India, following a hub-and-spoke model across 30+ locations (7 hubs and 28 spokes). It also runs a 15-bed day-care hospital in Janakpuri (Delhi NCR) and operates an in-house pharmacy through its wholly owned subsidiary, Gaudium International Pvt. Ltd.